Skip to main content
. 2013 Jul 9;8(7):e68248. doi: 10.1371/journal.pone.0068248

Table 3. Distribution of the MLST STs identified in the study.

Cats Patients p-value3 Fleas
La Rioja Catalonia Total Clinical picture Total
MLST rrs 1 Stray Pet Barnyard CSD Others 2
ST1 I 0 0 0 0 0 7.3% (3/41) 60.0% (3/5) 13.0% (6/46) 0.0289 4 0
ST2 I 0 0 25.0% (1/4) 0 2.6% (1/39) 0 20.0% (1/5) 2.2% (1/46) 1 0
ST3 I 0 0 0 0 0 9.8% (4/41) 0 8.7% (4/46) 0.1212 0
ST5 II 71.4% (15/21) 80.0% (4/5) 50.0% (2/4) 75.0% (3/9) 61.5% (24/39) 58.4% (24/41) 20.0% (1/5) 54.3% (25/46) 0.5187 100% (3/3)
ST6 II 19.0% (4/21) 20% (1/5) 25.0% (1/4) 0 15.4% (6/39) 0 0 0 0.0075 4 0
ST7 II 0 0 0 11.1% (1/9) 2.6% (1/39) 0 0 0 0.4588 0
ST8 I 0 0 0 11.1% (1/9) 2.6% (1/39) 24.4%(10/41) 0 21.7% (10/46) 0.0095 4 0
ST9 II 0 0 0 44.4% (4/9) 10.3% (4/39) 0 0 0 0.0406 4 0
ST31 II 4.8% (1/21) 0 0 0 2.6% (1/39) 0 0 0 0.4588 0
ST32 I 4.8% (1/21) 0 0 0 2.6% (1/39) 0 0 0 1 0
Total 21 5 4 9 39 41 5 46 3
1

rrs: 16S rRNA genotyping.

2

Other symptoms different from CDS.

3

Fisher’s exact test performed with the frequencies of each individual STs in cats and patients.

4

Statistically significant differences.